統合型機械学習と実験的検証は,肺高血圧におけるミトコンドリア動力学に関連した候補バイオマーカーとしてFIS1を特定しました
Yu Zhang1,2, Qing Dai2,3, Lijun Gong2,3
1School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Cells
|February 12, 2026
まとめ
この研究は,FIS1発現の増加が,肺動脈の滑らかな筋肉細胞におけるミトコンドリアの断片化とフェロプトーシスを引き起こし,血管再構成に貢献することによって,肺高血圧 (PH) を誘発することを明らかにしています.
科学分野:
- ミトコンドリア生物学 ミトコンドリア生物学
- 心血管研究に関する研究.
- 分子病理学 分子病理学
背景:
- 肺高血圧 (PH) は,限られた治療法で複雑な肺血管の再構築を伴う.
- ミトコンドリアのダイナミクスはPHの病原性に関与しているが,重要な調節因子は定義されていない.
研究 の 目的:
- PHにおけるミトコンドリア動態を調節する遺伝子を識別し,機能的に特徴づけること.
- 肺動脈の滑らかな筋肉細胞 (PASMC) 機能障害とPHにおける特定された遺伝子の役割を調査する.
主な方法:
- ミトコンドリアの注釈を伴う統合されたトランスクリプトミックのデータ.
- WGCNAと機械学習を使用して,候補遺伝子を優先しました.
- 低酸素誘発PHマウスモデルと培養マウスPASMC (mPASMC) で分子および細胞測定を用いた検証された結果.
主要な成果:
- FIS1をPHに関連する重要な遺伝子として特定し,高い差別性能を示しました.
- 低酸素症はFIS1発現を増加させ,ミトコンドリアの断片化,膜ポテンシャル喪失,およびmPASMCにおけるROSの蓄積につながった.
- FIS1のノックダウンにより,mPASMCの増殖と移動が抑制され,ミトコンドリア損傷が軽減され,フェロプトーシスが弱まりました.
結論:
- FIS1は,ミトコンドリア分裂とフェロプトーシス経由でPH病原化に貢献し,異常なPASMCフェノタイプと血管再構築を促進します.
- この研究は,PHのミトコンドリア経路内のメカニズム的な洞察と潜在的な治療目標を提供します.
関連する概念動画
Pulmonary Hypertension: Classification and Pathogenesis
670
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
670
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
625
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
625
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
484
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
484
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
524
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
524
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
634
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
634
Reliability and Validity
14.1K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K


